Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice.

Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice.

Veure altres versions (1)

Treatment with monoclonal antibodies (mAbs) specific for CD25 (anti-CD25 mAb) has been shown to suppress growth of a variety of different tumours in mice. These studies did not however determine whether or not anti-CD25 mAbs facilitate tumour rejection by depletion of regulatory T cells or by bindin...

Descripció completa

Dades bibliogràfiques
Autors principals:	Jones, E, Dahm-Vicker, M, Simon, A, Green, A, Powrie, F, Cerundolo, V, Gallimore, A
Format:	Journal article
Idioma:	English
Publicat:	2002

Ítems similars

Depletion of CD25+ regulatory cells results in suppression of melanomagrowth and induction of autoreactivity in mice
per: Jones, E, et al.
Publicat: (2002)

Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens.
per: Golgher, D, et al.
Publicat: (2002)

The influence of CD25+ cells on the generation of immunity to tumour cell lines in mice.
per: Jones, E, et al.
Publicat: (2004)

Induction of inflammatory bowel disease in immunodeficient mice by depletion of regulatory T cells.
per: Read, S, et al.
Publicat: (2001)

Controlling Autoreactivity of CD4 T Cells by Local Tolerance Induction
per: Irmgard F&#246;Rster
Publicat: (1998-01-01)

Inhibition of innate immune responses to tumours by CD4+CD25+ regulatory T cells
per: Richards, H, et al.
Publicat: (2005)

The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen.
per: Bushell, A, et al.
Publicat: (2005)

The influence of macrophage inflammatory protein-1alpha on protective immunity mediated by antiviral cytotoxic T cells.
per: Jones, E, et al.
Publicat: (2003)

Human autoreactive T cells recognize CD1b and phospholipids.
per: Van Rhijn, I, et al.
Publicat: (2016)

Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells.
per: Mottet, C, et al.
Publicat: (2003)

Association of progressive CD4(+) T cell decline in SIV infection with the induction of autoreactive antibodies.
per: Takeo Kuwata, et al.
Publicat: (2009-04-01)

Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level.
per: Roncador, G, et al.
Publicat: (2005)

Cure of innate intestinal immune pathology by CD4+CD25+ regulatory T cells.
per: Maloy, K, et al.
Publicat: (2005)

CD4+CD25+ regulatory T cell depletion modulates anxiety and depression-like behaviors in mice.
per: Soo-Jeong Kim, et al.
Publicat: (2012-01-01)

Depletion of CD4+ CD25+ regulatory T cells promotes CCL21-mediated antitumor immunity.
per: Shuang Zhou, et al.
Publicat: (2013-01-01)

Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo.
per: Read, S, et al.
Publicat: (2006)

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer.
per: Sarah L Clarke, et al.
Publicat: (2006-12-01)

In Vivo Induction of Functionally Suppressive Induced Regulatory T Cells from CD4+CD25- T Cells Using an Hsp70 Peptide.
per: Martijn J C van Herwijnen, et al.
Publicat: (2015-01-01)

Correction: Depletion of CD4+ CD25+ Regulatory T Cells Promotes CCL21-Mediated Antitumor Immunity
Publicat: (2014-01-01)

Correction: Depletion of CD4 CD25 Regulatory T Cells Promotes CCL21-Mediated Antitumor Immunity.
Publicat: (2014-01-01)

Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells.
per: Lim, H, et al.
Publicat: (2005)

Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro.
per: Stephens, L, et al.
Publicat: (2001)

T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells.
per: Fahlén, L, et al.
Publicat: (2005)

CD4(+) regulatory T cells.
per: Read, S, et al.
Publicat: (2001)

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation.
per: Read, S, et al.
Publicat: (2000)

Once-monthly hemin suppresses inflammatory and autoreactive CD4+ T cell responses to robustly ameliorate experimental rheumatoid arthritis
per: Bingzhi Sun, et al.
Publicat: (2021-10-01)

Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases
per: Luca Perico, et al.
Publicat: (2024-02-01)

Antigen recognition by autoreactive CD4⁺ thymocytes drives homeostasis of the thymic medulla.
per: Magali Irla, et al.
Publicat: (2012-01-01)

CD4+CD25+Foxp3+ regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice.
per: Fangwei Liu, et al.
Publicat: (2010-01-01)

Re-Programming Autoreactive T Cells Into T-Regulatory Type 1 Cells for the Treatment of Autoimmunity
per: Patricia Solé, et al.
Publicat: (2021-07-01)

New insights into developmental fate decisions by autoreactive CD4 thymocytes
per: Xuguang Tai, et al.
Publicat: (2024-02-01)

c-Met is expressed by highly autoreactive encephalitogenic CD8+ cells
per: Mahdia Benkhoucha, et al.
Publicat: (2020-02-01)

CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms.
per: Maloy, K, et al.
Publicat: (2003)

Protein kinase C theta is dispensable for suppression mediated by CD25+CD4+ regulatory T cells.
per: Kerstin Siegmund, et al.
Publicat: (2017-01-01)

Atypical sideways recognition of CD1a by autoreactive γδ T cell receptors
per: Marcin Wegrecki, et al.
Publicat: (2022-07-01)

P47 THE ANTIRENAL AUTOREACTIVE CD4+ T CELL RESPONSE IN HUMAN LUPUS NEPHRITIS
per: S. Tesch, et al.
Publicat: (2016-11-01)

Gut environment-induced intraepithelial autoreactive CD4+ T cells suppress central nervous system autoimmunity via LAG-3
per: Atsushi Kadowaki, et al.
Publicat: (2016-05-01)

Depletion of Thymus-Derived CD4+CD25+ T Cells Abrogates the Suppressive Effects of α-galactosylceramide Treatment on Experimental Allergic Conjunctivitis
per: Atsuki Fukushima, et al.
Publicat: (2008-01-01)

Data on sulforaphane treatment mediated suppression of autoreactive, inflammatory M1 macrophages
per: Sanjima Pal, et al.
Publicat: (2016-06-01)

Corrigendum: Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases
per: Luca Perico, et al.
Publicat: (2025-01-01)